Litcius/Paper detail

Review of New-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia

Mahran Shoukier, Michal Kubiak, Jörge E. Cortes

2021Current Oncology Reports25 citationsDOI

Topics & Concepts

MedicineMyeloid leukemiaTyrosine kinaseNilotinibDasatinibClinical trialTyrosine-kinase inhibitorBosutinibOncologyInternal medicineIntensive care medicineImatinibCancerReceptorChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchHER2/EGFR in Cancer Research
Review of New-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia | Litcius